<DOC>
	<DOCNO>NCT01627912</DOCNO>
	<brief_summary>The purpose study investigate whether red white wine consumption acute effect postprandial biochemical marker related platelet aggregation , inflammation oxidative stress compare water 12.5 % ethanol aqueous solution consumption .</brief_summary>
	<brief_title>Acute Effects Wine Consumption Healthy Volunteers</brief_title>
	<detailed_description>The last year , epidemiologic study indicate regular moderate consumption alcohol associate low risk coronary heart disease heart attack , well low mortality . More specific , J U-shaped association alcohol consumption incidence coronary heart disease suggest , mean low disease risk moderate alcohol consumer abstainer heavy drinker . The scientific interest focus wine term `` French paradox '' introduce , order describe epidemiological observation French suffer relatively low incidence coronary heart disease , despite diet relatively rich saturate fat . The paradox attribute moderate consumption red wine French . Even though many clinical study occur since , report postprandial effect wine , mainly focus study oxidative stress marker endothelium dysfunction . Also , limit number publication refer postprandial wine effect upon platelet aggregation , indicative marker inflammation / thrombosis atherosclerosis . The limited clinical evidence prompt u investigate postprandial effect wine consumption upon platelet aggregation , inflammation oxidation marker , undertake clinical study crossover design . The subject randomly consume 4ml drink [ Robola Cabernet Sauvignon 12.5 % ethanol water ] /kg individual , parallel standardized meal , consist 30.8 % carbohydrate , 12.0 % proteins 53.1 % fat . The meal total energy 787.2 kcal .</detailed_description>
	<criteria>healthy nonobese smoker report slimming dietary regime abstainer alcohol consumption heavy drinker athletes subject medication , aspirin , may impact platelet aggregation surgical event may affect study outcome participant know diagnosis either hypertension diabetes subject medication</criteria>
	<gender>Male</gender>
	<minimum_age>26 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>wine</keyword>
	<keyword>inflammation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>postprandial intervention</keyword>
	<keyword>platelet aggregation</keyword>
	<keyword>haemostasis</keyword>
	<keyword>robola</keyword>
	<keyword>cabernet sauvignon</keyword>
	<keyword>alcohol</keyword>
	<keyword>PAF metabolism</keyword>
</DOC>